E
GRI Bio, Inc. GRI
$0.20 $0.012.60% NASDAQ
Recommendation
Prev Close
$0.20
Volume
1,899,230
Avg Vol (90D)
1,687,522
Market Cap
$2.81M
Dividend & Yield
--
52-Week Range
$0.18 - $11.90
P/E (TTM)
--
EPS (TTM)
-$24.11
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
GRI Bio Inc trading halted, news pending
1/24/2026 - TipRanks Financial Blog
GRI Bio Inc trading halted, news pending
1/24/2026 - The Fly
GRI Bio (NASDAQ:GRI) Shares Set to Reverse Split on Monday, January 26th
1/23/2026 - Ticker Report
GRI Bio Announces Reverse Stock Split
1/21/2026 - GuruFocus
GRI Bio announces 1-for-28 reverse stock split
1/21/2026 - The Fly
GRI Bio announces 1-for-28 reverse share split
1/21/2026 - Seeking Alpha - Healthcare
GRI Bio Announces Reverse Stock Split
1/21/2026 - Globe Newswire
GRI Bio Inc Extraordinary Shareholders Meeting Transcript
1/15/2026 - GuruFocus
GRI Bio, Inc. (NASDAQ:GRI) Short Interest Up 600.2% in December
1/13/2026 - Zolmax
GRI Bio (GRI) Reports Promising Data in IPF Treatment Study
1/8/2026 - GuruFocus
GRI Bio announces data from Phase 2a study in Idiopathic Pulmonary Fibrosis
1/8/2026 - TipRanks Financial Blog
GRI Bio announces data from Phase 2a study in Idiopathic Pulmonary Fibrosis
1/8/2026 - The Fly
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary ...
1/8/2026 - GuruFocus
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621
1/8/2026 - Globe Newswire
GRI Bio Announces Closing of $8.0 Million Public Offering
12/12/2025 - GuruFocus
GRI Bio Announces Closing of $8.0 Million Public Offering
12/12/2025 - Globe Newswire
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
12/11/2025 - GuruFocus
GRI Bio announces pricing of $8M public offering
12/11/2025 - SeekingAlpha.com: All News
GRI Bio announces pricing of $8M public offering
12/11/2025 - Seeking Alpha - Healthcare
GRI Bio (GRI) Announces Pricing of Public Offering
12/11/2025 - GuruFocus
GRI Bio prices 10.67M shares at 75c in public offering
12/11/2025 - TipRanks Financial Blog
GRI Bio prices 10.67M shares at 75c in public offering
12/11/2025 - The Fly
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
12/11/2025 - Globe Newswire
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
12/11/2025 - Benzinga
gri touts ipf safety edge lung function gains amid cash crunch
12/11/2025 - FierceBiotech.com - Biotech
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$11.26M
EBIT (TTM)
-$11.27M
Net Income (TTM)
-$15.10M
Balance Sheet
Total Assets (Q)
$4.78M
Total Debt (Q)
$84.00K
Total Liabilities (Q)
$2.79M
Book Value Per Share (Q)
$0.6097
Cash Flow
Cash from Operations (TTM)
-$9.21M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$8.52M
Net Change in Cash (TTM)
-$691.00K
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Loading...
Beta
2.60
7-Day Total Return
-15.38%
30-Day Total Return
-83.36%
60-Day Total Return
-89.62%
90-Day Total Return
-89.57%
Year to Date Total Return
-28.11%
1-Year Total Return
-98.07%
2-Year Total Return
-99.95%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Jan 22, 2026 - $0.18
52-week High
Jan 30, 2025 - $11.90
Valuation
Market Cap
$2.81M - Nano Cap
Enterprise Value
-$1.17M
Price/Sales (TTM)
--
Price/Book (Q)
0.33
Dividends and Shares
Shares Outstanding
2.62M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.gribio.com
Phone Number
619 400 1170
Address
2223 Avenida de la Playa
La Jolla, CA 92037
Country
United States
Year Founded
2009
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed